Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA017575-21
Application #
2086616
Study Section
Special Emphasis Panel (NSS)
Project Start
1978-05-01
Project End
1996-10-30
Budget Start
1995-05-01
Budget End
1996-10-30
Support Year
21
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Organized Research Units
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Davis, B M; McCurrach, M E; Taneja, K L et al. (1997) Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A 94:7388-93
Sobulo, O M; Borrow, J; Tomek, R et al. (1997) MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci U S A 94:8732-7
Flores, J F; Walker, G J; Glendening, J M et al. (1996) Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res 56:5023-32
Aburatani, H; Stanton Jr, V P; Housman, D E (1996) High-resolution physical mapping by combined Alu-hybridization/PCR screening: construction of a yeast artificial chromosome map covering 31 centimorgans in 3p21-p14. Proc Natl Acad Sci U S A 93:4474-9
Borrow, J; Shearman, A M; Stanton Jr, V P et al. (1996) The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 12:159-67
Coleman, A; Fountain, J W; Nobori, T et al. (1994) Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res 54:344-8
Lowe, S W; Bodis, S; Bardeesy, N et al. (1994) Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harb Symp Quant Biol 59:419-26
Lowe, S W; Jacks, T; Housman, D E et al. (1994) Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci U S A 91:2026-30
Lowe, S W; Bodis, S; McClatchey, A et al. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807-10
Petty, E M; Gibson, L H; Fountain, J W et al. (1993) Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). Am J Hum Genet 53:96-104

Showing the most recent 10 out of 37 publications